On May 8, 2019, Dr. Bing Li informed the China Biologic Products Holdings, Inc. that he was resigning from his positions as the CEO and a director of the Company due to personal reasons, effective immediately, and that his decision to resign did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices. On May 10, 2019, the board of directors of the Company appointed Mr. Joseph Chow to be the acting CEO of the Company and formed a search committee comprised of independent directors to seek a new CEO for the Company.